ACTOGENIX N.V.
9Patents
7Active
9Granted
43Portfolio score
Filing activity: Oct 17, 2003 → Dec 19, 2012 · 6 expiring within 5 years
Most-cited patents
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US8759088B2 | Lactococcus promoters and uses thereof | Human Necessities | 14 | Active |
| US7601799B2 | Methods and means to promote gut absorption | Human Necessities | 10 | Expired |
| US7780961B2 | Self-containing Lactococcus strain | Human Necessities | 9 | Expired |
| US9200249B2 | Method to improve Lactococcus preservation | Chemistry; Metallurgy | 3 | Active |
| US7592013B2 | Delivery of trefoil peptides | Chemistry; Metallurgy | 3 | Active |
| US8398995B2 | Method of inducing immune tolerance to type I diabetes | Human Necessities | 3 | Active |
| US8524246B2 | Treatment of immune disease by mucosal delivery of antigents using genetically modified Lactobacillus | Chemistry; Metallurgy | 2 | Active |
| US9017662B2 | Anti-TNF alpha producing lactic acid bacteria for the treatment of chronic enterocolitis | Chemistry; Metallurgy | 0 | Active |
| US8748126B2 | Induction of mucosal tolerance to antigens | Human Necessities | 0 | Active |
Source: USPTO / EPO open patent data. Counts and citation impact are objective bibliographic measures.